Products for Research Use Only
RegisterLogin

Dacetuzumab

CAT: 0804-HY-P99015-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99015-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]) . Dacetuzumab ((SGN-40) can be used for multiple myeloma research[1].
CAS Number
880486-59-9
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dacetuzumab.html
Purity
95.37
Solubility
H2O
Smiles
[Dacetuzumab]
Molecular Weight
(145 kDa)
References & Citations
[1]Mohamad Hussein, et al. A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma. Haematologica. 2010 May;95 (5) :845-8.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
MBS5818605Dacetuzumab
591775Dacetuzumab (CD40)
GTR18337600-01Dacetuzumab Antibody
DHD68908Research Grade Dacetuzumab
KDD68903Dacetuzumab ELISA Kit
E55B0341Dacetuzumab (Reference antibody)
KBI1253KRIBIOLISA™ Dacetuzumab ELISA
ABS-255-100ugDacetuzumab Biosimilar, Research Grade
ICH5030-200mgDacetuzumab Biosimilar - Research Grade
A2636-1mg*25Dacetuzumab (Anti-TNFRSF5 / CD40)

Popular Products